2.220
2.22 (0%)
As of Dec 20, 2024
Black Diamond Therapeutics, Inc. [BDTX]
Source:
Company Overview
Black Diamond Therapeutics, Inc is a clinical-stage oncology company focused on the development of MasterKey therapies to treat patients with genetically defined tumors.
| Country | United States |
| Headquarters | cambridge, massachusetts |
| Phone Number | (617) 252-0848 |
| Industry | manufacturing |
| CEO | Mark A. Velleca |
| Website | www.blackdiamondtherapeutics.com |